About Alembic Pharmaceuticals Ltd.

Overview 

 

Alembic Pharmaceuticals Limited is an Indian pharmaceutical company with its head office in Vadodra, Gujarat, India, and is the flagship company of the Alembic Group. Established in 1907, it manufactures and sells active pharmaceutical ingredients (APIs), bulk pharma chemicals, generic and branded formulations, herbal nutraceuticals and veterinary medicines.

 

The company’s primary focus areas are anti-infectives, analgesics and cough and cold medicines, and chronic therapies such as cardiology, diabetes, gynecology, gastrointestinal (GI), orthopedic, dermatology and respiratory. It sells pharmaceutical products both domestically and overseas to more than 75 countries, including the US, Europe, Australia and South Africa.

 

Alembic Pharmaceuticals Limited operates in the following business segments:

  • Active Pharmaceutical Ingredients (API), comprising independent manufacturing blocks for Macrolides, nonsteroidal anti-inflammatory drugs (NSAIDs) and other drugs
  • Bulk Pharma Chemicals
  • Formulations, comprising 150+ products in several therapeutic segments
  • Contract/Collaborated Research Services

In the fiscal year ending 31 March 2016, Alembic Pharmaceuticals Limited1 had:

  • A 1.73% share of the Indian formulations market 
  • A presence in 10 key therapeutic areas
  • 5 manufacturing facilities
  • 2 R&D Centres (Vadodra and Hyderabad) 
  • Spent ~11% of its 2015-16 revenues on R&D 
  • (among the top 10 revenue spends on R&D in India)
  • Launched 44 products across SKUs in the domestic market
  • An all India Rank of #19 in the Indian formulations market

 

 

Future Plans

  • Launch ~25 product SKUs in the current year
  • Increase market share in chronic therapies

 

Alembic Pharmaceuticals Limited is listed on the National Stock Exchange of India (NSE) and the Mumbai Stock Exchange (BSE).

 

Alembic Pharmaceuticals Limited at-a-glance

 

  • Employees   8000+
  • Revenues (31 March, 2016)   ~USD 474 million  
    (or ?3,145 crores)
  • Manufacturing Units 5
  • R&D Centres  
  • Cumulative ANDAS Filed 76
  • Cumulative ANDA Approvals    47
  • Cumulative DMFs Filed    81
  • Own Brands Launched (USA)    11

 

 

Approvals & Certifications

  • ISO-9002
  • ISO-14001 
  • ISO 27001 
  • FDA
  • Therapeutic Product Directorate (TPD)
  • MHRA
  • FDCA
  • Medicines Control Council (MCC)
  • EDQM
  • Department of Health & Ageing (Australia) 
  • German Regulatory Authority

*Sources:

http://www.alembic-india.com/index.php

Annual Report 2015-16

 

 

 

History

See Milestones below
 

 

Milestones

 

  • 1907

    • Established by the Amin family
    • Starts manufacturing tinctures and alcohol at Vadodra, Gujarat
  • 1940 – Starts manufacturing cough syrup, vitamins, tonics & sulphur drugs
  • 1961 – Penicillin plant is inaugurated by Lal Bahadur Shastri
  • 1967 – Starts manufacturing Vitamin B12
  • 1971 – Starts manufacturing Erythromycin for the first time in India
  • 1972 – Launches Althrocin, a brand of Erythromycin
  • 1997 – Althrocin becomes India’s top-selling brand
  • 1999 – Starts manufacturing synthetic organic API
  • 2000 – Receives ISO 14000 certification for Vadodra facility
  • 2001 – Starts manufacturing Cephalosporin C
  • 2006 – Receives FDA approval for API facilities
  • 2007 – Acquires Non-Oncology Business of Dabur Pharma Ltd.

(i.e. Indian cardiology, GI and gynaecology brands)

  • 2009 – Addresses chronic therapies through multiple marketing divisions
  • 2010
    • Demerges pharmaceuticals business from Alembic – APL listed
    • Total ANDAS filed: 38, Total DMFs filed: 53 & receives approval for 15
  • 2012 – Forms a joint venture for NCE research
  • 2013
    • Launches first NDA with a partner
    • Commences filing in EU, Australia and Brazil
  • 2014 – Forms a 50:50 joint venture in Algeria
  • 2015
    • Launches Aripiprazole on day-1
    • Establishes a front-end for marketing in the US
  • 2016 – Establishes a joint venture with Orbicular Inc.

BOARD OF DIRECTORS

 

  • Chairman & CEO: Mr. Chirayu Amin
  • Managing Director: Mr. Pranav Amin, Mr. Shuanak Amin
  • Director Finance & CFO: Mr. RK Baheti
  • Independent Directors: Mr. KG Ramanathan, Mr. Pranav Parikh, Mr. Paresh Saraiya, Mr. Milin Mehta, Dr. Archana Hingorani

 

 

CONTACTS

 

CORPORATE & REGISTERED OFFICE

Alembic Limited

Alembic Road

Vadodara – 390 003

Gujarat, INDIA

 

Web: http://www.alembicpharmaceuticals.com/

Tel: +91-265-2280550

+91-265-2280880

+91-265-3053333

 

Fax: +91-265-2281508

+91-265-2284728

Email: infoal@alembic.co.in

MUMBAI OFFICE

2nd Floor, Prime Corporate Park

Behind ITC Grand Maratha Sheraton

Sahar Road, Andheri (E)

Mumbai – 99

India

 

Tel: +91-22-30611698

+91-22-30611682

 

 

 

 

 

MANUFACTURING FACILITIES

Alembic Road

Vadodara – 390 003

Gujarat, India

 

Panelav, Tal. Halol

Dist. Panchmahal – 389 350

Gujarat, India

 

Plot No. 21, 22

EPIP - Phase I

Jhamajri, Baddi, Tehsil – Nalagarh

Dist. Solan

Himachal Pradesh, India

 

Village Karakhadi

Taluka Padra Dist. Vadodara

Gujarat, India

 

 

RESEARCH CENTRE

Division of Alembic Limited

Alembic Campus

Vadodara – 390003

 

For General Enquires:

+91-265-300-7989

+91-265-300-7874

 

For Chemistry Requirements:

+91-265-300-7652

 

For Bioequivalence / Bioavailability studies:

+91-265-3007300

 

 

 

 

 

 

 

As per the company’s website and/or 2015-16 Annual Report



Comment!
 
 






* Indicates mandatory field.
Please wait while comments are being sent...